Trademark Alertz ®
Search
Trademark
Owner
Trademark: SYNTHORX 1988814
Word
SYNTHORX
ID
1988814
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
12 February 2019
Registration Date
12 February 2019
Renewal Date
12 February 2029
Owner(s)
Synthorx, Inc.
Service
Spruson & Ferguson
Goods and Services:
Class 5
:
Pharmaceutical preparations and substances
;
Protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, and infectious diseases
;
protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases
;
protein therapeutics namely, pharmaceutical preparations for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics
;
protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors
;
non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes
;
pharmaceutical preparations, namely, synthetic proteins for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics
Class 42
:
Medical research
;
scientific and pharmaceutical research and development
;
scientific research in the field of DNA
;
pharmaceutical research and development
;
laboratory research services in the field of pharmaceuticals
;
pharmaceutical research in the field of protein therapeutics
;
pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, genetics and phenomics, pathology and forensics, proteomics, and veterinary medicine and diagnostics
;
providing medical and scientific research information in the field of pharmaceuticals and clinical trials
;
pharmaceutical research using a semi-synthetic organism for use in drug development
;
pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties
;
pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents